TCRT Earnings — Alaunos Therapeutics, Inc. Common Stock Post-ER Performance | BigEarnings
TCRT — Alaunos Therapeutics, Inc. Common Stock
XNAS · Healthcare · Biotechnology
Price$2.85
Market Cap$69.6M
P/E—
52W Range$1.67 – $6.20
Next Earnings2026-08-13
About Alaunos Therapeutics, Inc. Common Stock
Alaunos Therapeutics Inc is a preclinical-stage biopharmaceutical company focused on the development of novel, orally administered small-molecule therapeutics for obesity and related metabolic disorders, such as metabolic dysfunction-associated steatotic liver disease (MASLD, a type of fatty liver disease). The program aims to develop a differentiated, non-hormonal, non-incretin approach, unlike hormone-based treatments like GLP-1 drugs. It has a single reportable and operating segment related to biopharmaceutical research and development.
